An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...
MOSCOW, August 21. /TASS/. Researchers at Russia’s Gamaleya Center have completed pre-clinical trials of a nasal spray coronavirus vaccine and are ready to launch clinical trials, the center’s ...